Sometimes the worst has to happen before seeking medical attention.
Severe Hypercalcaemia -Chronic Tophaceous Gout as the Responsible Cause?
EuRopEan EndoCRinoloGy 
Figure 1: Physical Examination Findings and Description

Non-tender tophi from 1 to 6 cm were obvious at inspection. A-C. Wrists, metacarpophalangeal, proximal and distal interphalangeal articulations. D. Elbows. E. Ankles and first metatarsophalangeal joint. Radiographs of upper and lower extremities revealed bone erosions with the characteristic 'overhanging' edges.
Biopsy histopathology result showed deposits of monosodium urate (MSU) crystals surrounded by granulomatous inflammation.
Diagnosis
The most common cause of severe hypercalcaemia in a hospitalised setting is malignancy. The responsible mechanisms are known to be secondary to local osteolysis, PTHrP mediated, 1,25-dihydroxyvitamin D (1,25(OH) 2 D 3 , calcitriol) secretion and ectopic parathyroid hormone (PTH). 1 PTHrP, as seen in our patient, is the most common cause and has usually been described in non-metastatic solid tumours (bladder, breast and squamous cell tumors) and non-Hodgkin lymphomas. In this sense, a bone scan and a positron emission tomography-computed tomography (PET-CT) were negative for metastasis and malignancy. Nevertheless, usually associated with mild/moderate levels of hypercalcaemia, hyperparathyroidism, overall, is known to be the most common cause of hypercalcaemia and was also ruled out. 2 As causes of secondary hyperucricaemia, drugs and/or diet supplements were excluded, as well as haemolytic disorders, obesity, psoriasis and myeloproliferative and/or lymphoproliferative disorders. There was no family history consistent with an inherited defect that could lead to purine overproduction.
The association of chronic tophaceous gout with severe hypercalcaemia is extremely rare and has been usually described to be secondary calcitriol that results in hypercalcaemia and/or hypercalciuria. 3, 4 In this case calcitriol levels were normal and this possibility was excluded.
In addition to this, after treatment with prednisone the levels of calcitriol were no different. On the other hand, PTHrP had never been, another well-known cause of mild calcium elevations. 5 It is likely that in this case this was an exacerbating rather than the primary factor. Local osteolysis was considered but even in advanced rheumatoid arthritis and other severe causes of bone erosions, hypercalcaemia has never been reported.
Management
Now rarely seen, chronic tophaceous gout represents the last stage of the natural history of gout. It is characterised by collections of solid urate in connective tissues such as cartilage, bursae, soft tissues, tendons, ligaments and enthesis. It is composed of deposits of MSU crystals that are usually surrounded by granulomatous inflammation. 1 Although clinical signs of acute inflammation sometimes occur in tophi, this is unusual; swelling accompanying a tophus is most often due to the mass of crystals itself. 2 Treatment was initiated with calcitonin, hydration with intravenous saline solution at 250 ml/hour and prednisone with a consequent improvement in renal function and normocalcaemia restoration. 6 PTH, 25-dihydroxyvitamin D, PTHrP and calcitriol returned to normal values and after 3 weeks, the patient was discharged with prednisone, NSAIDs and colchicine. At 6 months follow-up the tophi had improved, calcium levels were within the normal range and no pain was reported. In this case the overproduction of PTHrP and the immobilisation were the responsible mechanisms of the hypercalcaemia that was restored after prompt and optimal treatment. n
